Trial Condition(s):

Multiple Sclerosis

Betaferon use in children and adolescents with Multiple Sclerosis

Bayer Identifier:

2008/01743

ClinicalTrials.gov Identifier:

NCT03577977

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The objective of this study is to determine efficacy, safety and tolerability of interferon beta-1b for multiple sclerosis (MS) in children and adolescents

Inclusion Criteria
- patients with symptoms consistent with the diagnosis of a demyelinating CNS disease
- patients who received at least one injection of Betaferon before age 18 (before their 18th birthday)
- recorded use of at least one dose of Betaferon before January 1, 2008
Exclusion Criteria
- Diagnosis other then MS or a demyelinating CNS disease

Trial Summary

Enrollment Goal
70
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Russia

Status
Completed
 

Trial Design